| # | Drug | Count |
|---|---|---|
| 0 | CIPROFLOXACIN | 2 |
| 1 | CIPROFLOXACIN HYDROCHLORIDE | 2 |
| 2 | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | 2 |
| 3 | DANAZOL | 2 |
| 4 | DEFERASIROX | 2 |
| 5 | ERYTHROPOIETIN | 2 |
| 6 | FUROSEMIDE | 2 |
| 7 | ADALIMUMAB | 1 |
| 8 | AXICABTAGENE CILOLEUCEL | 1 |
| 9 | CARBAMAZEPINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITAPIVAT | 1 | 0.0008 |
| 1 | DANAZOL | 2 | 0.0007 |
| 2 | DEFERIPRONE | 1 | 0.0003 |
| 3 | HYOSCYAMINE SULFATE | 1 | 0.0001 |
| 4 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 5 | ERYTHROPOIETIN | 2 | 0.0001 |
| 6 | CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE | 2 | 0.0001 |
| 7 | DEFERASIROX | 2 | 0.0001 |
| 8 | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE | 1 | 0.0000 |
| 9 | FLUDARABINE PHOSPHATE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Iron Chelator [EPC] | 3 |
| 1 | Androgen [EPC] | 2 |
| 2 | Corticosteroid [EPC] | 2 |
| 3 | Loop Diuretic [EPC] | 2 |
| 4 | Alkylating Drug [EPC] | 1 |
| 5 | Atypical Antipsychotic [EPC] | 1 |
| 6 | BCL-2 Inhibitor [EPC] | 1 |
| 7 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 9 | Genetically-modified Autologous T Cells [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 1 | Iron Chelator [EPC] | 3 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | Androgen [EPC] | 2 | 0.0001 |
| 4 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Mood Stabilizer [EPC] | 1 | 0.0000 |
| 6 | Loop Diuretic [EPC] | 2 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 1 | 0.0000 |